| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |